Seiji Kojima

ORCID: 0000-0003-4125-5467 · 4 papers in corpus · active 2000-2016

Study types

  • article 3
  • review 1
review 2016
Allogeneic hematopoietic stem cell transplantation for dyskeratosis congenita
·doi:10.1097/moh.0000000000000290

PURPOSE OF REVIEW: Dyskeratosis congenita is an inherited bone marrow failure syndrome caused by defects in telomere maintenance. Hematopoietic stem cell transplantation (HSCT) is the only curative treatment for bone marrow failure because …

article 2011
Antithymocyte Globulin (ATG), Cyclosporine (CyA), and Danazol Versus ATG and CyA As Treatment for Children with Aplastic Anemia: Result of Matched-Pair Analysis
·doi:10.1182/blood.v118.21.2400.2400

Abstract Abstract 2400 Introduction: Immunosuppressive therapy (IST) with antithymocyte globulin (ATG) plus cyclosporine A (CyA) has been the standard therapy for aplastic anemia (AA) patients. Recently, telomerase shortening was observed i…

article 2000
Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia
·doi:10.1182/blood.v96.6.2049.h8002049_2049_2054

A prospective multicenter trial of 119 children 1 to 18 years of age with newly diagnosed aplastic anemia (AA) was conducted, comparing treatment using antithymocyte globulin (ATG), cyclosporine (CyA), and danazol (DAN) with or without rhG-…

article 2000
Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia
·doi:10.1182/blood.v96.6.2049

A prospective multicenter trial of 119 children 1 to 18 years of age with newly diagnosed aplastic anemia (AA) was conducted, comparing treatment using antithymocyte globulin (ATG), cyclosporine (CyA), and danazol (DAN) with or without rhG-…